G. M. Bartelds - Concepedia

Author

G. M. Bartelds

Also Known As

Bartelds, G.M., G M Bartelds, G. M. Bartelds, G. Margret Bartelds, GEERTJE M. BARTELDS, Geertje M Bartelds, Geertje M. Bartelds, Geertje Margret Bartelds

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Sanquin Amsterdam UMC Location Vrije Universiteit Amsterdam University of Amsterdam Amsterdam UMC Location University of Amsterdam

About

G. M. Bartelds is an author at Sanquin specializing in autoimmunity, rheumatology, and autoantibodies.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	231
2	Immunology	2	2	231
3	Rheumatology	2	2	231
4	Allergy	1	1	72
5	Pharmacology	1	1	159

G. M. Bartelds

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up G. M. Bartelds JAMA	2011	752
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis G. M. Bartelds, Carla A. Wijbrandts, Michael T. Nurmohamed, Annals of the Rheumatic Diseases	2007	562
Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study G. M. Bartelds, Carla A. Wijbrandts, Michael T. Nurmohamed, Annals of the Rheumatic Diseases	2009	222
The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept Anna Jamnitski, G. M. Bartelds, Michael T. Nurmohamed, Annals of the Rheumatic Diseases	2010	177
A novel method for the detection of antibodies to adalimumab in the presence of drug reveals “hidden” immunogenicity in rheumatoid arthritis patients Pauline A. van Schouwenburg, G. M. Bartelds, M. Hart, Journal of Immunological Methods Rheumatoid DisorderRheumatologyHidden ” ImmunogenicityAutoimmune DiseaseMedicine	2010	159
Venous and arterial thromboembolic events in adalimumab‐treated patients with antiadalimumab antibodies: A case series and cohort study L.-A. Korswagen, G. M. Bartelds, C. Krieckaert, Arthritis & Rheumatism	2011	117
Anti‐adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin‐10 gene polymorphisms G. M. Bartelds, Carla A. Wijbrandts, Michael T. Nurmohamed, Arthritis & Rheumatism InflammationRheumatologyRheumatoid DisorderAllergyAutoimmune Disease	2009	72
Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study G. M. Bartelds, Els de Groot, Michael T. Nurmohamed, Arthritis Research & Therapy	2010	67
Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis. Wouter H Bos, G. M. Bartelds, Margret H. M. T. De Koning, PubMed	2008	66
Perceived work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6‐month course of TNF inhibitors: prospective intervention study and partial economic evaluation Jan L. Hoving, G. M. Bartelds, J. K. Sluiter, Scandinavian Journal of Rheumatology	2009	44

Page 1